Denosumab causing severe, refractory hypocalcaemia in a patient with chronic kidney disease

Denosumab is a fully human monoclonal antibody that is being increasingly used for the treatment of osteoporosis and prevention of skeletal-related events (SREs) in bone metastases from primary tumours. It has improved efficacy, better tolerability and convenient administration via subcutaneous rout...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Case Rep
Asıl Yazarlar: Saleem, Sameer, Patel, Sabah, Ahmed, Adnan, Saleem, Nasir
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2018
Konular:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5990053/
https://ncbi.nlm.nih.gov/pubmed/29848528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-224068
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller